Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rieg

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of Internal Medicine|July 2, 2020
Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor?H Luxenburger, L Sturm, P Biever, et al.
Microbiology Spectrum|October 13, 2025
Frequent high-level rifaximin resistance in <i>Escherichia coli</i> associated with long-term treatment of patients with liver cirrhosis: a prospective, controlled studyL Boll, W V Kern, S Schuster, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2016
Combination antimicrobial therapy in patients with Staphylococcus aureus bacteraemia-a post hoc analysis in 964 prospectively evaluated patientsS Rieg, I Joost, V Weiß, et al.
Psychosomatics|November 20, 2012
Serotonin reuptake inhibitors and bleeding risks in major orthopedic proceduresHamid R Tavakoli, Marlene DeMaio, Nathaniel C Wingert, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their chargeH Steffen, S Rieg, I Wiedemann, et al.
Infection|January 26, 2024
Complexity of patients with or without infectious disease consultation in tertiary-care hospitals in GermanyC Meyer-Schwickerath, C Weber, D Hornuss, et al.
Letters in Applied Microbiology|May 13, 2015
α-Defensins partially protect human neutrophils against Panton-Valentine leukocidin produced by Staphylococcus aureusE Cardot-Martin, J S Casalegno, C Badiou, et al.
The Journal of Infection|June 19, 2021
Vertebral osteomyelitis in patients with Staphylococcus aureus bloodstream infection: Evaluation of risk factors for treatment failureN Jung, A Ernst, I Joost, et al.
Infection|March 30, 2013
Delay in the administration of appropriate antimicrobial therapy in Staphylococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort studyA J Kaasch, S Rieg, J Kuetscher, et al.
Infection|October 6, 2025
Antimicrobial Stewardship in German non-university hospitals: baseline status and impact of a multifaceted AMS intervention within the prospective ID ROLL OUT studyR Giesen, G Först, G Fink, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Internal Medicine|July 2, 2020
Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor?H Luxenburger, L Sturm, P Biever, et al.
Microbiology Spectrum|October 13, 2025
Frequent high-level rifaximin resistance in <i>Escherichia coli</i> associated with long-term treatment of patients with liver cirrhosis: a prospective, controlled studyL Boll, W V Kern, S Schuster, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2016
Combination antimicrobial therapy in patients with Staphylococcus aureus bacteraemia-a post hoc analysis in 964 prospectively evaluated patientsS Rieg, I Joost, V Weiß, et al.
Psychosomatics|November 20, 2012
Serotonin reuptake inhibitors and bleeding risks in major orthopedic proceduresHamid R Tavakoli, Marlene DeMaio, Nathaniel C Wingert, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their chargeH Steffen, S Rieg, I Wiedemann, et al.
Infection|January 26, 2024
Complexity of patients with or without infectious disease consultation in tertiary-care hospitals in GermanyC Meyer-Schwickerath, C Weber, D Hornuss, et al.
Letters in Applied Microbiology|May 13, 2015
α-Defensins partially protect human neutrophils against Panton-Valentine leukocidin produced by Staphylococcus aureusE Cardot-Martin, J S Casalegno, C Badiou, et al.
The Journal of Infection|June 19, 2021
Vertebral osteomyelitis in patients with Staphylococcus aureus bloodstream infection: Evaluation of risk factors for treatment failureN Jung, A Ernst, I Joost, et al.
Infection|March 30, 2013
Delay in the administration of appropriate antimicrobial therapy in Staphylococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort studyA J Kaasch, S Rieg, J Kuetscher, et al.
Infection|October 6, 2025
Antimicrobial Stewardship in German non-university hospitals: baseline status and impact of a multifaceted AMS intervention within the prospective ID ROLL OUT studyR Giesen, G Först, G Fink, et al.
Pageof 6